KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Change in Acquisitions & Divestments (2016 - 2025)

BeOne Medicines (ONC) has disclosed Change in Acquisitions & Divestments for 11 consecutive years, with $1.8 million as the latest value for Q1 2025.

  • On a quarterly basis, Change in Acquisitions & Divestments fell 32.2% to $1.8 million in Q1 2025 year-over-year; TTM through Sep 2025 was $1.8 million, a 98.34% decrease, with the full-year FY2024 number at $2.7 million, down 99.61% from a year prior.
  • Change in Acquisitions & Divestments was $1.8 million for Q1 2025 at BeOne Medicines, down from $2.7 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $1.1 billion in Q1 2021 to a low of -$10000.0 in Q4 2021.
  • A 5-year average of $357.1 million and a median of $256.3 million in 2022 define the central range for Change in Acquisitions & Divestments.
  • Peak YoY movement for Change in Acquisitions & Divestments: tumbled 100.0% in 2021, then skyrocketed 2112300.0% in 2022.
  • BeOne Medicines' Change in Acquisitions & Divestments stood at -$10000.0 in 2021, then surged by 2112300.0% to $211.2 million in 2022, then plummeted by 49.95% to $105.7 million in 2023, then plummeted by 97.49% to $2.7 million in 2024, then crashed by 32.2% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for ONC's Change in Acquisitions & Divestments are $1.8 million (Q1 2025), $2.7 million (Q1 2024), and $105.7 million (Q4 2023).